Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
NCT03040778Phase 3Active, not recruiting
- Sponsor
- University of Washington
- Start
- Apr 2018
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline, tocopherol in medication-related osteonecrosis of the jaw (MRONJ), sponsored by University of Washington. Started Apr 2018; status: active, not recruiting.
02
Drugs
pentoxifyllinetocopherol
03
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT03040778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03040778.